{"entity":{"type":"insider","cik":"0001472131","url":"/insider/0001472131","json_url":"/insider/0001472131.json","name":"Menichella Daniel L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2010-09-01","last":"2021-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Menichella Daniel L","source":"filing","n_filings":4,"first_seen":"2010-09-01","last_seen":"2021-02-26"}],"transactions":[{"id":4475336,"accession":"0001209191-21-014857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-014857","line_url":"/filing/0001209191-21-014857#line-1","is_derivative":false,"issuer_cik":"0001472131","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001472131","owner_cik":"0001472131","owner_name":"Menichella Daniel L","owner_url":"/insider/0001472131","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":230000.0,"total_display":"230,000.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-26","scope":"insider"},{"id":8811229,"accession":"0001209191-15-006568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-006568","line_url":"/filing/0001209191-15-006568#line-2","is_derivative":false,"issuer_cik":"0001273636","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001273636","owner_cik":"0001472131","owner_name":"Menichella Daniel L","owner_url":"/insider/0001472131","role":"Officer (V.P. & Chief Business Officer)","officer_title":"V.P. & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1996.0,"shares_display":"1,996","price_per_share":24.9,"price_display":"24.90","price_state":"stated","total_value":49700.4,"total_display":"49,700.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-26","scope":"insider"},{"id":6680953,"accession":"0001209191-14-077687","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-077687","line_url":"/filing/0001209191-14-077687#line-2","is_derivative":false,"issuer_cik":"0001273636","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001273636","owner_cik":"0001472131","owner_name":"Menichella Daniel L","owner_url":"/insider/0001472131","role":"Officer (V.P. & Chief Business Officer)","officer_title":"V.P. & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":20.83,"price_display":"20.83","price_state":"stated","total_value":187470.0,"total_display":"187,470.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-23","scope":"insider"},{"id":7691706,"accession":"0001223203-10-000206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223203-10-000206","line_url":"/filing/0001223203-10-000206#line-1","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"V9SNSIJ","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472131","owner_name":"Menichella Daniel L","owner_url":"/insider/0001472131","role":"Officer (Sr. VP, Business Development)","officer_title":"Sr. VP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":22.0483,"price_display":"22.05","price_state":"stated","total_value":2204830.0,"total_display":"2,204,830.00","shares_owned_after":17013.0,"shares_owned_after_display":"17,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-30","filed_date":"2010-09-01","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001751299","name":"Kaleido Biosciences, Inc.","url":"/issuer/0001751299","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2021-02-26","last_seen":"2021-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001273636","name":"APPLIED GENETIC TECHNOLOGIES CORP","url":"/issuer/0001273636","role":"Officer (V.P. & Chief Business Officer)","n_filings":2,"first_seen":"2014-12-23","last_seen":"2015-01-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001405197","name":"Talecris Biotherapeutics Holdings Corp.","url":"/issuer/0001405197","role":"Officer (Sr. VP, Business Development)","n_filings":1,"first_seen":"2010-09-01","last_seen":"2010-09-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001472131","retrieved_at":"2026-08-21T06:21:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}